SE431544B - Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat - Google Patents

Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat

Info

Publication number
SE431544B
SE431544B SE7614620A SE7614620A SE431544B SE 431544 B SE431544 B SE 431544B SE 7614620 A SE7614620 A SE 7614620A SE 7614620 A SE7614620 A SE 7614620A SE 431544 B SE431544 B SE 431544B
Authority
SE
Sweden
Prior art keywords
pyrimidon
derivatives
preparation
pharmacologically active
analogy procedure
Prior art date
Application number
SE7614620A
Other languages
English (en)
Swedish (sv)
Other versions
SE7614620L (sv
Inventor
T H Brown
G J Durant
C R Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE7614620L publication Critical patent/SE7614620L/xx
Publication of SE431544B publication Critical patent/SE431544B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7614620A 1975-12-29 1976-12-28 Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat SE431544B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (2)

Publication Number Publication Date
SE7614620L SE7614620L (sv) 1977-06-30
SE431544B true SE431544B (sv) 1984-02-13

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7614620A SE431544B (sv) 1975-12-29 1976-12-28 Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat

Country Status (37)

Country Link
JP (1) JPS5283388A (no)
AR (1) AR222290A1 (no)
AT (1) AT360024B (no)
AU (1) AU508123B2 (no)
BE (1) BE849810A (no)
BG (1) BG29722A3 (no)
CA (1) CA1073458A (no)
CH (1) CH631981A5 (no)
CS (1) CS203995B2 (no)
DD (1) DD128588A5 (no)
DE (1) DE2658267A1 (no)
DK (1) DK587076A (no)
EG (1) EG12439A (no)
ES (1) ES454656A1 (no)
FI (1) FI62668C (no)
FR (1) FR2336935A1 (no)
GR (1) GR62441B (no)
HU (1) HU175171B (no)
IE (1) IE45082B1 (no)
IL (1) IL51040A (no)
IT (2) IT1124740B (no)
LU (1) LU76481A1 (no)
MW (1) MW5076A1 (no)
MX (1) MX5119E (no)
NL (1) NL7614538A (no)
NO (1) NO146396C (no)
NZ (1) NZ182759A (no)
OA (1) OA05526A (no)
PH (1) PH14723A (no)
PL (1) PL104376B1 (no)
PT (1) PT65949B (no)
RO (1) RO72475A (no)
SE (1) SE431544B (no)
SU (1) SU791235A3 (no)
YU (1) YU311676A (no)
ZA (1) ZA767198B (no)
ZM (1) ZM14376A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IN151188B (no) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
DE2962542D1 (en) * 1979-04-11 1982-06-03 Smith Kline French Lab Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (no) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
PT65949A (pt) 1977-01-01
IE45082L (en) 1977-06-29
NO146396C (no) 1982-09-22
IL51040A0 (en) 1977-02-28
ATA960876A (de) 1980-05-15
LU76481A1 (no) 1977-06-15
HU175171B (hu) 1980-05-28
SE7614620L (sv) 1977-06-30
DK587076A (da) 1977-06-30
RO72475A (ro) 1982-10-26
FR2336935B1 (no) 1980-03-21
CH631981A5 (en) 1982-09-15
AU2097676A (en) 1978-07-06
FI62668B (fi) 1982-10-29
NO764370L (no) 1977-06-30
CA1073458A (en) 1980-03-11
PL104376B1 (pl) 1979-08-31
FI763664A (no) 1977-06-30
NO146396B (no) 1982-06-14
JPS5283388A (en) 1977-07-12
AR222290A1 (es) 1981-05-15
PT65949B (pt) 1978-06-15
GR62441B (en) 1979-04-12
IT1124740B (it) 1986-05-14
BG29722A3 (en) 1981-01-15
IE45082B1 (en) 1982-06-16
FR2336935A1 (fr) 1977-07-29
IT7919107A0 (it) 1979-01-05
PH14723A (en) 1981-11-13
ES454656A1 (es) 1977-11-16
IL51040A (en) 1980-12-31
FI62668C (fi) 1983-02-10
SU791235A3 (ru) 1980-12-23
CS203995B2 (en) 1981-03-31
YU311676A (en) 1983-01-21
MW5076A1 (en) 1978-02-08
BE849810A (fr) 1977-06-23
DE2658267A1 (de) 1977-07-07
ZM14376A1 (en) 1977-08-22
ZA767198B (en) 1977-11-30
AU508123B2 (en) 1980-03-13
JPS6129355B2 (no) 1986-07-05
NZ182759A (en) 1978-06-02
MX5119E (es) 1983-03-24
EG12439A (en) 1979-09-30
AT360024B (de) 1980-12-10
DD128588A5 (de) 1977-11-30
NL7614538A (nl) 1977-07-01
OA05526A (fr) 1981-04-30

Similar Documents

Publication Publication Date Title
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO792829L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO143744C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benz(de)isokinolin-derivater
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO145197C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfolinforbindelser
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7614620-8

Effective date: 19941128

Format of ref document f/p: F